Renaissance Technologies's CODX Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 28,917 shares of Co-Diagnostics, Inc. (CODX) worth $298,428, representing 0.00% of the portfolio. First purchased in 2019-Q4, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in CODX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 10,216 shares. Largest reduction occurred in Q4 2022, reducing 1,686 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Co-Diagnostics (CODX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Co-Diagnostics (CODX) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +534 | New Buy | 534 | $26.22 |
| Q1 2020 | -534 | Sold Out | 0 | $0.00 |
| Q2 2021 | +2,043 | New Buy | 2,043 | $247.67 |
| Q3 2021 | +4,107 | Add 201.03% | 6,150 | $291.87 |
| Q4 2021 | +3,667 | Add 59.63% | 9,817 | $267.90 |
| Q1 2022 | +9,718 | Add 98.99% | 19,535 | $185.41 |
| Q2 2022 | +3,248 | Add 16.63% | 22,783 | $168.28 |
| Q3 2022 | +710 | Add 3.12% | 23,493 | $96.28 |
| Q4 2022 | -1,686 | Reduce 7.18% | 21,807 | $0.08 |
| Q1 2023 | -197 | Reduce 0.90% | 21,610 | $0.04 |
| Q2 2023 | +180 | Add 0.83% | 21,790 | $0.03 |
| Q3 2023 | -577 | Reduce 2.65% | 21,213 | $31.82 |
| Q4 2023 | -646 | Reduce 3.05% | 20,567 | $39.92 |
| Q1 2024 | -554 | Reduce 2.69% | 20,013 | $33.58 |
| Q2 2024 | -446 | Reduce 2.23% | 19,567 | $37.50 |
| Q3 2024 | -643 | Reduce 3.28% | 18,924 | $37.50 |
| Q4 2024 | -403 | Reduce 2.13% | 18,521 | $22.50 |
| Q1 2025 | -177 | Reduce 0.96% | 18,344 | $9.29 |
| Q2 2025 | +357 | Add 1.94% | 18,701 | $8.41 |
| Q3 2025 | +10,216 | Add 54.63% | 28,917 | $10.32 |
Renaissance Technologies's Co-Diagnostics Investment FAQs
Renaissance Technologies first purchased Co-Diagnostics, Inc. (CODX) in Q4 2019, acquiring 534 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Co-Diagnostics, Inc. (CODX) for 20 quarters since Q4 2019.
Renaissance Technologies's largest addition to Co-Diagnostics, Inc. (CODX) was in Q3 2025, adding 28,917 shares worth $298,428.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 28,917 shares of Co-Diagnostics, Inc. (CODX), valued at approximately $298,428.
As of the Q3 2025 filing, Co-Diagnostics, Inc. (CODX) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Co-Diagnostics, Inc. (CODX) was 28,917 shares, as reported at the end of Q3 2025.